Arena Pharmaceuticals Inc EBIT margin
Qual é o EBIT margin de Arena Pharmaceuticals Inc?
O EBIT margin de Arena Pharmaceuticals Inc é -1,133,840.74%
Qual é a definição de EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin de empresas na Setor Health Care em NASDAQ em comparação com Arena Pharmaceuticals Inc
O que Arena Pharmaceuticals Inc faz?
Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas
Empresas com ebit margin semelhantes a Arena Pharmaceuticals Inc
- Nimy Resources Ltd tem EBIT margin de -1,962,988.89%
- Akora Resources Ltd tem EBIT margin de -1,900,440.63%
- Deepti Alloy Steel tem EBIT margin de -1,676,280.26%
- Carpinienne de Participations tem EBIT margin de -1,474,500.00%
- Thin Film Electronics ASA tem EBIT margin de -1,362,200.00%
- Allogene Therapeutics Inc tem EBIT margin de -1,342,523.81%
- Arena Pharmaceuticals Inc tem EBIT margin de -1,133,840.74%
- Aurum Resources Ltd tem EBIT margin de -887,391.20%
- Eastern Metals tem EBIT margin de -812,601.10%
- Willow Biosciences tem EBIT margin de -803,860.14%
- Psyched Wellness tem EBIT margin de -703,101.31%
- Cannon Resources Ltd tem EBIT margin de -666,400.00%
- Tamboran Resources Ltd tem EBIT margin de -530,273.27%